CANADA LIFE ASSURANCE Co Buys 27,747 Shares of American Healthcare REIT, Inc. (NYSE:AHR)

CANADA LIFE ASSURANCE Co lifted its position in American Healthcare REIT, Inc. (NYSE:AHR - Free Report) by 16.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 193,797 shares of the company's stock after purchasing an additional 27,747 shares during the quarter. CANADA LIFE ASSURANCE Co owned about 0.13% of American Healthcare REIT worth $5,504,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in AHR. GAMMA Investing LLC increased its stake in American Healthcare REIT by 104.1% in the 4th quarter. GAMMA Investing LLC now owns 988 shares of the company's stock worth $28,000 after acquiring an additional 504 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new stake in American Healthcare REIT in the third quarter worth $28,000. Carolina Wealth Advisors LLC bought a new stake in American Healthcare REIT in the fourth quarter worth $29,000. Richardson Capital Management LLC purchased a new stake in American Healthcare REIT during the fourth quarter valued at $29,000. Finally, Decker Retirement Planning Inc. purchased a new position in shares of American Healthcare REIT in the 4th quarter worth $37,000. 16.68% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have weighed in on the company. Morgan Stanley boosted their price objective on American Healthcare REIT from $36.00 to $37.00 and gave the stock an "overweight" rating in a research note on Tuesday, March 25th. Royal Bank of Canada restated an "outperform" rating and issued a $34.00 target price on shares of American Healthcare REIT in a report on Wednesday, March 19th. KeyCorp cut their price target on shares of American Healthcare REIT from $35.00 to $34.00 and set an "overweight" rating on the stock in a report on Monday, March 31st. JMP Securities set a $35.00 price objective on shares of American Healthcare REIT in a research note on Tuesday, March 4th. Finally, Citigroup reaffirmed an "outperform" rating on shares of American Healthcare REIT in a research note on Tuesday, March 4th. Seven equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, American Healthcare REIT currently has a consensus rating of "Buy" and an average target price of $33.33.

American Healthcare REIT Price Performance

Shares of AHR stock opened at $30.41 on Thursday. The company has a market capitalization of $4.79 billion, a P/E ratio of -63.35, a P/E/G ratio of 1.57 and a beta of 1.42. The company's 50-day simple moving average is $29.39 and its two-hundred day simple moving average is $28.16. American Healthcare REIT, Inc. has a one year low of $13.35 and a one year high of $31.61. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.37 and a quick ratio of 0.37.

American Healthcare REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, April 17th. Investors of record on Monday, March 31st were paid a $0.25 dividend. The ex-dividend date was Monday, March 31st. This represents a $1.00 annualized dividend and a yield of 3.29%. American Healthcare REIT's dividend payout ratio (DPR) is currently -370.37%.

About American Healthcare REIT

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.